Therapeutic equivalency of generic antiepileptic drugs: Results of a survey

Epilepsy and Behavior

Volumn 5, Issue 6, 2004, Pages 995-998

  Wilner, Andrew N ^a  

^a NONE   (United States)

Author keywords

Adverse events; Antiepileptic drugs; Bioequivalence; Brand; Cost effective; Food and Drug Administration; Generic; Seizures; Substitution

Indexed keywords

ANTICONVULSIVE AGENT; CLOZAPINE; GENERIC DRUG; MYLAN; PHENYTOIN;

ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; FOOD AND DRUG ADMINISTRATION; HEALTH SURVEY; HUMAN; MEDICAL SPECIALIST; NEUROLOGY; SEIZURE; SIDE EFFECT;

ANTICONVULSANTS; DATA COLLECTION; DRUGS, GENERIC; EPILEPSY; HEALTH CARE SURVEYS; HUMANS; PHYSICIAN'S ROLE; THERAPEUTIC EQUIVALENCY;

EID: 10844260714     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2004.05.011     Document Type: Article

References (13)

1. Christensen T.P. Kirking D.M. Ascione F.J. et al. Drug product selection: Legal issues J. Am. Pharm. Assoc. 41 2001 868-874
2. Williams RL. Therapeutic equivalence of generic drugs. Response to National Association of Boards of Pharmacy [letter, April 16, 1997]. Available at http://www.fda.gov/cder/news/ntiletter.htm. Accessed May 18, 2004
3. Kirking D.M. Ascione F.J. Perspective on generic pharmaceuticals: some conclusions J. Am. Pharm. Assoc. 41 2001 826-828
4. Nuwer M.R. Browne T.R. Dodson W.E. et al. Generic substitution for antiepileptic drugs Neurology 40 1990 1647-1651
5. Code of Federal Regulations, Title 21, Volume 5, Revised as of April 1, 2003, US Government Printing Office via GPO Access: 21CFR320.33
6. Mofsen R. Balter J. Case reports of the reemergence of psychotic symptoms after conversion from brand-name clozapine to a generic formulation Clin. Ther. 23 2001 1720-1731
7. Guberman A. Corman C. Generic substitution for brand name antiepileptic drugs: A survey Can J. Neurol. Sci. 27 2000 37-43
8. Wilner A.N. Physicians underestimate the frequency of generic carbamazepine substitution: Results of a survey and review of the problem Epilepsy Behav. 3 2002 522-525
9. Approved drug products with therapeutic equivalence evaluations (the Orange Book) 21st ed. Washington, DC: US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drug Evaluation and Research, Office of Information Technology, Division of Data Management and Services. Available at: Http://www.fda.gov/cder/ob/default.htm . Accessed January 23, 2004
10. Wilder B.J. Leppik I. Hietpas T.J. et al. Effect of food on absorption of Dilantin Kapseals and Mylan extended phenytoin sodium capsules Neurology 57 2001 582-589
11. Davit B.M. Singh G.J.P. Conner D.P. Effect of food on absorption of Dilantin Kapseals and Mylan extended phenytoin sodium capsules [letter] Neurology 58 2002 666
12. Yu BP, Chong US, Maguire GA. Is generic fluoxetine effective? J Affect Disord, in press
13. Fowler F.J. Nonresponse: Implementing a sample design Survey Research Methods 2nd ed. 1993 Sage London